Selumetinib NDA Submission for Neurofibromatosis Type 1 (NF1) granted Priority Review
AstraZeneca and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration... Read More
A close look into: AstraZeneca and Merck’s strategic oncology collaboration
AstraZeneca and Merck & Co., Inc., (Merck; known as MSD outside of the US and Canada) today announced that they have entered... Read More
MSD divests six brands to Zydus Cadila in India
Posted on30 Dec 2016
TagsAxeten, brand acquisition, Deca-Durabolin, Durabolin, MSD, Multiload, Sicastat, Sustanon, Zydus cadila
Comments0
Ahmedabad-based drug maker Zydus Cadila has acquired six brands from the Indian unit of US pharmaceutical giant Merck for an undisclosed amount.... Read More
Sanofi Pasteur, MSD to terminate joint vaccines operations in Europe
Posted on10 Mar 2016
Comments0
Sanofi Pasteur, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs, and MSD, known as Merck in... Read More
Lilly and Merck’s Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA Combination Trial
Eli Lilly and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib... Read More